Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin Farhat Nasim23 May 2019 11:59 AM ISTOgivri is the first trastuzumab biosimilar approved in Canada and the second biosimilar from Biocon and Mylan's joint portfolio approved in the...
Lupin launches generic version of Pulmicort Respules Inhalation Suspension Farhat Nasim23 May 2019 9:30 AM ISTLupin's product is a generic version of AstraZeneca Pharmaceuticals LP's Pulmicort Respules Inhalation Suspension, 0.5 mg/2 mL.New Delhi: Drug maker...
Cipla Q4 net profit jumps 133 pc at Rs 357.68 crore; plans fundraising of Rs 6000 crore Garima23 May 2019 9:15 AM ISTCipla has also decided to raise funds of up to Rs 6,000 crore.New Delhi: Drug major Cipla Wednesday reported over two-fold jump in consolidated net...
Novartis plans gene therapy price lower than $4 million to $5 million range Medical Dialogues Bureau23 May 2019 9:00 AM ISTNovartis has previously said it could price the treatment in a range of $1.5 million to $5 million.BOSTON: Novartis AG's top executive said on...
Medtronic says won't recall pacemakers in India; in discussion with CDSCO Farhat Nasim22 May 2019 11:57 AM ISTStressing that it was "not a case of product recall", Medtronic India said, "We are in proactive discussion with CDSCO".New Delhi: In contrast to the...
Panacea Biotec gets USFDA nod for chemotherapy drug Azacitidine Farhat Nasim22 May 2019 9:45 AM ISTAzacitidine is a chemotherapy drug used to treat myelodysplastic syndromes (MDS) with annual sales of about USD 110 million in US markets as per IQVIA...
Varian to acquire Cancer Treatment Services International for Rs 1980 crore Garima22 May 2019 9:30 AM ISTThese fast-growing offerings will allow Varian to expand its solutions while helping to support the continued growth trajectory of the company’s...
Alembic Pharma gets USFDA nod for Solifenacin Succinate tablets to treat overactive bladder Farhat Nasim22 May 2019 9:15 AM ISTThe company has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Solifenacin...
Merck to buy cancer drug developer Peloton Therapeutics for $1.05 billion in cash Garima22 May 2019 9:00 AM ISTMerck Inc's lead drug candidate, PT2977, will be studied in a late-stage study for treating renal cell carcinoma.New Delhi: Merck & Co Inc said on...
Glenmark Pharma gets USFDA nod for generic version of Vesicare tablets Farhat Nasim21 May 2019 11:31 AM ISTThe approved product, Solifenacin Succinate tablet is a generic version of Vesicare tablets of Astellas Pharma US, Inc.New Delhi: Glenmark...
CCI dismisses complaint against Cipla, chemist body over alleged non-supply of medicines Farhat Nasim21 May 2019 9:45 AM ISTNew Delhi: In a major relief to Mumbai based Cipla Ltd and Bengal Chemist and Druggists Association (BCDA), the Competition Commission of India has...
GSK Pharma Q4 net profit rises 16.56 percent to Rs 123 crore Garima21 May 2019 9:30 AM ISTThe company had posted a net profit of Rs 105.55 crore for the corresponding period of the previous fiscal, GSK said in a filing to the BSE.New Delhi:...
